# CincyTech

> CincyTech is a VC fund in Cincinnati backing Software and Health Care. See 122 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Cincinnati, United States
- Total investments: 122
- Last investment: Jul 2026
- Lead investor: 54%
- Fund size: $12M
- Last fund: Jul 2023
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/cincytech-usa
- X (Twitter): http://twitter.com/Cincy_Tech
- Website: http://cincytechusa.com
- Facebook: http://www.facebook.com/cincytechventures

CincyTech is a VC fund in Cincinnati focused on Software and Health Care. CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.

## Contacts

5 contacts available for CincyTech. Shizune tracks 7 team members at CincyTech. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cincytech?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $250k–$3.9M |
| Series A | $300k–$30M |
| Series B | $2.5M–$11M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 20 | 16% |
| Health Care | 19 | 16% |
| Information Technology | 12 | 10% |
| Biotechnology | 11 | 9% |
| Medical Device | 11 | 9% |

117 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 42 | 34% |
| Series A | 28 | 23% |
| Series B | 13 | 11% |
| Funding Round | 6 | 5% |
| Grant | 5 | 4% |

9 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| John M. Rice | Managing Director | 17 | https://shizune.co/investors/profile/john-m-rice |
| Ashley Keating | Chief Financial Officer | 0 | https://shizune.co/investors/profile/ashley-keating-ca87 |
| Douglas Groh | DManaging Director | 1 | https://shizune.co/investors/profile/douglas-groh |
| Emma Off | President | 1 | https://shizune.co/investors/profile/emma-off-6e4b |
| Jamie Easterling | Executive in Residence | 0 | https://shizune.co/investors/profile/jamie-easterling-012d |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ravee Optics | Ravee Optics is a satellite company that provides optical communications and ultracompact link solutions. | $6M | Seed | Jul 06, 2026 |  |
| TeamCentral | TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems. | $3.9M | Seed | May 27, 2025 |  |
| Invirsa | Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone. | $7.7M | Series B | Jun 14, 2023 |  |
| Vixiv | Voxel integrates advanced mathematics and artificial intelligence to build functionally graded meta-materials for high-performance applications. Voxel delivers performance leaps in defense, automotive, aerospace, medical, industrial, and other demanding domains, allowing customers to unlock new possibilities. | $1.7M | Seed | May 23, 2023 |  |
| Amify | Amify delivers turnkey, award-winning services to help brands launch, manage and continually optimize their Amazon channel strategy. As the first Amazon-as-a-Service provider, we serve as an outsourced Amazon team, which helps companies own their brand on the world’s largest ecommerce platform by leveraging cross channel data to increase sales andimprove customer experience. As of 2021, Amify is responsible for more than $200M of goods sold on Amazon, Amify transforms the platform into one of our client’s top two channels. The Amify team brings vast expertise to sellers from branding and advertising to data analytics and business operations. From our high-performing, beautiful storefronts, to our optimized forecasting and logistics, we’re an embedded extension of our client’s team, whose mission is to make it painless for clients to win on Amazon. | $4.2M | Series B | May 23, 2023 |  |
| Tembo | Dev-first, fully-extensible managed Postgres. | $6.5M | Seed | Apr 17, 2023 |  |
| IncludeHealth | IncludeFitness provides an internationally awarded digital health platform that pairs HIPAA compliant cloud software with inclusive rehabilitation equipment to lower the barriers of maintaining physical health for all ages and abilities while optimizing the delivery of care. Its integrated software, The IFCloud, is the engine that provides profoundimprovements in provider efficacy and efficiency with features such as outcomes-based data collection, automated documentation, and cloud collaboration. Its inclusive functional trainer, The Access Strength, provides unprecedented versatility and ease-of-use for all demographics while capturing objective data through infusing universal design with technology. The platform is offered through a monthly subscription and provides better outcomes with higher quality and lower costs throughout the continuum of care.It was founded in 2009 and is headquartered in Cincinnati, Ohio. | $11M |  | Feb 16, 2023 |  |
| LainaHealth | IncludeHealth partners with musculoskeletal providers to extend their reach beyond the clinic and unlock hybrid care models. Powered by computer vision, IncludeHealth's platform digitizes physical therapy and delivers personalized, measured care through patients' devices without needing additional hardware or downloads. Recognized withover 40 innovation and health awards, IncludeHealth's platform is utilized by health systems, physical therapy networks, orthopedic practices, and the government for remote therapeutic monitoring and value-based care. | $11M | Venture - Series Unknown | Feb 16, 2023 |  |
| Genetesis | Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened. | $17.5M | Series C | Oct 06, 2022 |  |
| XII Medical | XII Medical is a medical device developer company. It develops a minimally invasive outpatient technology for the treatment of obstructive sleep apnea. | $30M | Series A | May 05, 2022 |  |

10 of 122 investments shown.

## Co-investors
- [Queen City Angels](https://shizune.co/investors/profile/queen-city-angels) — VC Fund, 10 deals together
- [North Coast Ventures](https://shizune.co/investors/profile/north-coast-angel-fund) — VC Fund, 9 deals together
- [The Brandery](https://shizune.co/investors/profile/the-brandery) — VC Fund, 8 deals together
- [Vine St. Ventures](https://shizune.co/investors/profile/vine-st-ventures) — VC Fund, 8 deals together
- [Cincinnati Children’s](https://shizune.co/investors/profile/cincinnati-childrens) — VC Fund, 6 deals together
- [JobsOhio](https://shizune.co/investors/profile/jobsohio) — VC Fund, 6 deals together

## Similar investors

### Similar industry
- [1745 Ventures](https://shizune.co/investors/profile/bertelsmann-digital-media-investments) — VC Fund
- [Knight Enterprise Fund](https://shizune.co/investors/profile/knight-enterprise-fund) — VC Fund
- [Advancit Capital](https://shizune.co/investors/profile/advancit-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical Device Investors](https://shizune.co/investors/medical-device-investors)
- [Medical Device VC Funds](https://shizune.co/investors/medical-device-vc-funds)
- [Medical Device Investors in United States](https://shizune.co/investors/medical-device-investors-united-states)
- [Medical Device VC Funds in United States](https://shizune.co/investors/medical-device-vc-funds-united-states)
- [Digital Media Investors](https://shizune.co/investors/digital-media-investors)
- [Digital Media VC Funds](https://shizune.co/investors/digital-media-vc-funds)

## FAQ

### What does CincyTech invest in?

CincyTech invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Series A stage. Most of the 122 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is CincyTech's check size?

CincyTech typically joins rounds of $250k–$3.9M at Seed, $300k–$30M at Series A and $2.5M–$11M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CincyTech participates in.

### How do I contact CincyTech?

Public channels for CincyTech include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CincyTech?

The team at CincyTech includes John M. Rice (Managing Director), Ashley Keating (Chief Financial Officer) and Douglas Groh (DManaging Director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co